文献速递主动脉疾病

2型内漏对腹主动脉瘤腔内修复术后长期结局的影响:日本全国医院组织网络研究

Influence of Type 2 Endoleaks on Long-Term Outcomes after Endovascular Repair for Abdominal Aortic Aneurysms: A National Hospital Organization Network Study for Abdominal Aortic Aneurysms in Japan.
PubMed 文献 · Ann Vasc Surg · 2019-10-17

该研究基于日本14家国立医院550例EVAR患者,比较随访12个月内检出2型内漏的135例与无内漏的415例,中位随访5年。结果显示2型内漏组瘤囊增大、晚期干预及动脉瘤相关死亡的5年累积发生率均显著更高,提示2型内漏影响EVAR长期结局。

要点

  • 2型内漏组5年瘤囊增大累积发生率为30.7%±4.4%,显著高于无内漏组的8.7%±1.6%(P=0.002)。
  • 2型内漏组5年晚期干预累积发生率为25.3%±4.1%,显著高于无内漏组的7.6%±1.4%(P<0.001)。
  • 2型内漏组5年动脉瘤相关死亡累积发生率为2.6%±1.4%,显著高于无内漏组的0.3%±0.3%(P=0.015)。

核心结论

  • 2型内漏影响EVAR术后长期结局,表现为瘤囊增大、晚期干预和动脉瘤相关死亡累积发生率升高。
  • 存在2型内漏时,较大的瘤囊保守观察不可取,因其倾向于扩张。

研究设计与样本

  • 回顾性队列研究,纳入2007至2013年在日本14家国立医院接受EVAR的550例患者。
  • 135例在EVAR后12个月内随访CT诊断2型内漏为EL2(+)组,415例无内漏为EL2(-)组。
  • 采用累积发生率函数法估计结局,并用Fine-Gray风险模型分析预后因素;中位随访5年。

主要发现

  • EL2(+)组5年瘤囊增大、晚期干预、动脉瘤相关死亡累积发生率分别为30.7%±4.4%、25.3%±4.1%、2.6%±1.4%。
  • EL2(-)组对应5年累积发生率分别为8.7%±1.6%、7.6%±1.4%、0.3%±0.3%。
  • 两组瘤囊增大(P=0.002)、晚期干预(P<0.001)、动脉瘤相关死亡(P=0.015)累积发生率差异显著。
  • 30例因2型内漏伴瘤囊增大接受经导管弹簧圈栓塞作为一线治疗;其中20例有栓塞后CT瘤囊行为信息,无一例瘤囊缩小,18例瘤囊扩张。

关键数值与推荐

  • 2型内漏诊断依据EVAR后12个月内随访CT。
  • 5年累积发生率差异有统计学意义:瘤囊增大P=0.002,晚期干预P<0.001,动脉瘤相关死亡P=0.015。

临床怎么用

  • EVAR术后12个月内应通过CT识别2型内漏,并加强瘤囊增大和晚期干预风险的监测。
  • 对2型内漏伴较大瘤囊者不建议保守观察,因瘤囊倾向于扩张。
  • 经导管弹簧圈栓塞后多数瘤囊仍扩张,需谨慎评估其作为一线治疗的效果。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although endovascular repair (EVAR) is the first-line treatment for abdominal aortic aneurysm, type 2 endoleak (EL), which is associated with late sac enlargement or rupture, remains a concern. The present study aimed to assess the influence of type 2 EL on long-term outcomes after EVAR. METHODS: Among 550 patients who underwent EVAR between 2007 and 2013 at 14 Japanese national hospitals, 135 patients had type 2 EL diagnosed on follow-up computed tomography (CT) within 12 months after EVAR (EL2[+] group) and 415 patients did not have EL within 12 months (EL2[-] group). The cumulative incidences of sac enlargement, late intervention, and aneurysm-related death after EVAR were estimated using the cumulative incidence function method, and prognostic factors were investigated using the Fine-Gray hazard model. RESULTS: The median follow-up period was 5 years, and the 5-year cumulative incidence rates of sac enlargement, late intervention, and aneurysm-related death were 30.7% ± 4.4%, 25.3% ± 4.1%, and 2.6% ± 1.4%, respectively, in the EL2(+) group, and 8.7% ± 1.6%, 7.6% ± 1.4%, and 0.3% ± 0.3%, respectively, in the EL2(-) group. The cumulative incidence rates of sac enlargement (P = 0.002), late intervention (P < 0.001), and aneurysm-related death (P = 0.015) were significantly different between the 2 groups. As the first-line treatment for sac enlargement with type 2 EL, transcatheter coil embolization was performed in 30 patients. Information about sac behavior on CT after coil embolization was available in 20 of the 30 patients. Among these patients, no patients experienced sac shrinkage, and the aneurysmal sac dilated after coil embolization in 18 patients. CONCLUSIONS: Type 2 EL affects the long-term outcomes after EVAR. It is not recommended to observe large aneurysmal sacs conservatively as they tend to dilate in the presence of type 2 EL.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sakaki M, Handa N, Onohara T, et al. Influence of Type 2 Endoleaks on Long-Term Outcomes after Endovascular Repair for Abdominal Aortic Aneurysms: A National Hospital Organization Network Study for Abdominal Aortic Aneurysms in Japan. Ann Vasc Surg. 2019. PMID: 31629849. doi:10.1016/j.avsg.2019.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。